Xi'an Wanlong Pharmaceutical Co., Ltd. is a comprehensive modern pharmaceutical enterprise founded in 1995, primarily producing formulations, APIs, and intermediates with GMP and DMF compliance. The Yangling facility spans 200,000 sq.m. with 18 production lines for injections, tablets, capsules, powder, and raw materials.
Large-scale pharmaceutical manufacturing with extensive capacity: 1.3 billion infusion units/year, 3 billion solid dose units/year, 1 billion cephalosporin units/year, 100 ton/year API production. Specializes in dextran, tirofiban, L-malic acid, and fexofenadine APIs.
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.